Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer.
Nensa F, Stattaus J, Morgan B, Horsfield MA, Soria JC, Besse B, Gounant V, Khalil A, Seng K, Fischer B, Krissel H, Laurent D, Christoph D, Eberhardt WE, Gauler TC.
Nensa F, et al. Among authors: stattaus j.
Future Oncol. 2014 Apr;10(5):823-33. doi: 10.2217/fon.13.248.
Future Oncol. 2014.
PMID: 24799063